Skip to content
2000
Volume 3, Issue 1
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Liver enzyme abnormalities occur frequently in patients diagnosed with Coronavirus disease 2019 (COVID-19). It has been suggested that patients with severe acute liver injury are more likely to be admitted to intensive care, require intubation or renal replacement therapy and their mortality rate is higher than patients without severe acute liver injury. This review article explores the possible aetiologies of liver dysfunction seen in patients with COVID-19 and also the effect of COVID-19 on patients with pre-existing liver disease. Finally, we suggest clinical approaches to treating a patient with liver enzyme disturbance and COVID-19 and also caring for patients who require liver transplantation in the COVID-19 era.

Loading

Article metrics loading...

/content/journals/covid/10.2174/2666796702666211005142343
2022-01-01
2025-10-13
Loading full text...

Full text loading...

/content/journals/covid/10.2174/2666796702666211005142343
Loading

  • Article Type:
    Review Article
Keyword(s): coronavirus disease 2019; COVID-19; hepatitis; liver disease; liver transplant; MAFLD
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test